Skip to content

The trial of comparison onthe effect of "MANYO-REISHI premium" on immune function and QOL -Randomized Control Trial-

The trial of comparison onthe effect of "MANYO-REISHI premium" on immune function and QOL -Randomized Control Trial- - "MANYO-REISHI premium" Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030220
Enrollment
40
Registered
2017-12-01
Start date
2017-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Supplement(6 tablets a day) Placebo supplement(6 tablets a day)

Sponsors

CLINICAL CREATIVE CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Japanese men and women aged 20 to 80 at the time of acquiring consent 2) Those who judged that a principal Investigator will meet this trial aim 3) Those who can take the test supplement for 3 months 4) If the subject are doing diet therapy or exercise therapy, those who do not change during the trial duration 5) Those who obtains written consent

Exclusion criteria

Exclusion criteria: 1)Those who suffering from severe cerebrovascular disease, heart disease, liver disease, renal disease, gastrointestinal disease, infection requiring notification 2)Those who suspected of suffering from acute infection such as influenza 3)who are receiving treatment for autoimmune diseases, chronic inflammatory diseases, allergic diseases 4)Those who received vaccination within 12 weeks before ingestion, or those who wish to consume during the test period 5)Those who with a history of major operations in the digestive system such as gastrectomy, gastrointestinal suture, intestinal resection 6)Those who with significant changes in physical condition before and after menopause 7)Those who with significant abnormalities in blood pressure measurement and blood test 8)Those who with advanced anemia 9)Those who are likely to have allergic symptoms to drugs or foods(especially mushrooms, soybeans, wheat) 10)Those who take chinese herbs, health foods, supplements(mushrooms, seaweeds, nucleic acids, Yeast, lactic acid bacteria, etc)and a medice that affect immune function, regularly. The subject will be able to take these kinds of things, if a principal investigator will permit those items. the subject should write it down in detail on the subject diary. 11)Those who are extremely irregular in excessive smoking and alcohol consumers, and lifestyle habits such as meals and sleep 12)Those who donate 400 ml blood within 12 weeks, 200 ml blood within 4 weeks or ingredient donation within 2 weeks 13)Those who are pregnant, nursing or who want pregnancy during the exam 14)Those who are participating in other clinical trials, or participating within 1 month 15)Those who are judged unqualified as a subject by a principal investigator

Design outcomes

Primary

MeasureTime frame
VAS(visual analogue scale)of any symptoms of cold and tiredness.

Countries

Japan

Contacts

Public ContactKAZUO TAKAYASU

AKIYAMA SANGYO Co.,Ltd. Special Sales Division

takayasu@akiyamasangyo.com03-3668-0981

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026